Indication

Cyclic neutropenia

Cyclic neutropenia is a rare hematologic disorder characterized by regular, oscillatory fluctuations in neutrophil production, typically manifesting in infancy or early childhood. Read more about Cyclic neutropenia

8 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Cyclic neutropenia therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Cyclic neutropenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cyclic neutropenia.

Cyclic neutropenia is a rare hematologic disorder characterized by regular, oscillatory fluctuations in neutrophil production, typically manifesting in infancy or early childhood.

It is primarily caused by autosomal dominant or sporadic mutations in the *ELANE* gene, which disrupt granulopoiesis through accelerated apoptosis of myeloid progenitor cells in the bone marrow.

Affected individuals experience severe neutropenia recurring at approximately 21-day intervals and lasting three to five days.

During these nadir periods, patients are susceptible to recurrent fevers, aphthous stomatitis, gingivitis, pharyngitis, and bacterial skin or respiratory infections, while remaining largely asymptomatic between episodes.

Personalize your experience

Follow Cyclic neutropenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it